Hepatitis B vaccine - Sinovac Biotech
Latest Information Update: 17 Dec 2021
Price :
$50 *
At a glance
- Originator Sinovac Biotech
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for preclinical development in Hepatitis-B in China (Parenteral)
- 31 Dec 2014 Sinovac Biotech submits Clinical Trial Application to the China FDA for Hepatitis B infections
- 01 Dec 2014 Preclinical trials in Hepatitis B in China (Parenteral) before December 2014